Why we use our clinically characterised ashwagandha extract at the level used in the published research — not generic powder at the level used in the published research

The problem with "ashwagandha"

If you walk into a supplement shop in the UK in 2026 and pick up five different ashwagandha products, you'll find:

- Five different doses (typically 100mg to 1,200mg) - Five different extract ratios (often unspecified) - Five different standardisation claims (or none at all) - Sometimes the whole root, sometimes the leaf, sometimes a mix

None of these are wrong, exactly. But four of them aren't the form used in the majority of the published research. And the research on adaptogens is dose- and form-specific in ways most consumers aren't told about.

Why our clinically characterised ashwagandha extract specifically

our clinically characterised ashwagandha extract is a full-spectrum root extract of Withania somnifera, produced under GMP conditions by . It is standardised to a minimum of its principal active compound (withanolides) (the principal active compound class), and crucially, it is the form used in the majority of published human clinical work on ashwagandha — including the studies most often cited for adaptogenic effects.

When a published study shows an effect at "the level used in the published research of ashwagandha root extract, standardised to its principal active compound (withanolides), taken once daily for 8 weeks," the form used in that study is almost always our clinically characterised ashwagandha extract or Sensoril. Generic ashwagandha powder at the level used in the published research is not the same intervention. That doesn't mean it doesn't work — it means it wasn't tested.

We use our clinically characterised ashwagandha extract because we want what's inside our capsule to match what's been tested in the published literature, dose-for-dose. That feels like the minimum standard for a premium product.

How we dose it

The Barakah Pill contains the level used in the published research of our clinically characterised ashwagandha extract per daily four-capsule serving. This is the dose used in most of the cited human research and is at the upper end of what's typically supplied in UK adult-formula supplements.

What we can't claim

There is no UK or EU-authorised health claim for ashwagandha. This means we cannot tell you what it will or won't do for you. We can only tell you:

- What the published research is studying (adaptogenic effects on the body's stress-response system) - What form we use (our clinically characterised ashwagandha extract, full-spectrum root, 5%+ withanolides) - What dose we use (600mg daily, matching the published studies) - What you should do (take it daily for at least 8 weeks before deciding if it's worth it for you)

If you have a specific clinical concern — chronic stress, sleep issues, low energy — speak with your GP first. Ashwagandha is not a substitute for clinical care, and several of the most-studied effects are themselves modest. The brands telling you otherwise have not read the same studies we have.

A note on regulatory monitoring

As of 2026, ashwagandha is under active FSA risk assessment in the UK — a process triggered by Denmark's earlier dose cap in 2023. The FSA assessment is examining whether the standard adult supplemental dose should be capped, restricted, or unchanged.

We monitor this monthly. If the FSA's final ruling requires us to reformulate, we have a contingency plan in place (a swap to a Rhodiola Rosea standardised extract at an equivalent dose). We'll communicate any change to subscribers before it ships.

This is the kind of thing premium supplement brands should be transparent about. We'd rather you know there's a regulatory process running than be surprised by a quiet formulation change.

Reading further

- (our clinically characterised ashwagandha extract manufacturer documentation): ixoreal.com - FSA risk assessment process: food.gov.uk - Lopresti et al. (2019), "An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract." Medicine 98(37).